| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| PDCD4 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN406016 | 1 kit | ORIGENE TECHNOLOGIES |
| PDCD11 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN418724 | 1 kit | ORIGENE TECHNOLOGIES |
| Human LOX-1/OLR1 ELISA Kit from ORIGENE TECHNOLOGIES | EA100518 | 8x12 divisible strip | ORIGENE TECHNOLOGIES |
| PHOSPHO2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN410618 | 1 kit | ORIGENE TECHNOLOGIES |
| Phospho1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN513232 | 1 kit | ORIGENE TECHNOLOGIES |
| PHOSPHO1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN414434 | 1 kit | ORIGENE TECHNOLOGIES |
| Phospholamban (PLN) from ORIGENE TECHNOLOGIES | LY400944 | 100 ug | ORIGENE TECHNOLOGIES |
| Phospho2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN513233 | 1 kit | ORIGENE TECHNOLOGIES |
| Human Brain; Oligoastrocytoma, anaplastic from ORIGENE TECHNOLOGIES | CS815128 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Brain; Oligodendroglioma from ORIGENE TECHNOLOGIES | CS813929 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Brain; Oligodendroglioma from ORIGENE TECHNOLOGIES | CS800036 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Brain; Oligodendroglioma, anaplastic from ORIGENE TECHNOLOGIES | CS712447 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Brain; Oligodendroglioma, anaplastic from ORIGENE TECHNOLOGIES | CS800985 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Brain; Oligodendroglioma, anaplastic from ORIGENE TECHNOLOGIES | CS811057 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Brain; Oligodendroglioma, anaplastic from ORIGENE TECHNOLOGIES | CS510901 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Brain; Oligodendroglioma, anaplastic from ORIGENE TECHNOLOGIES | CS602792 | 5x5um | ORIGENE TECHNOLOGIES |
| Phospholipase D family, member 3 (PLD3), transcript variant 2 from ORIGENE TECHNOLOGIES | LY415872 | 100 ug | ORIGENE TECHNOLOGIES |
| Phospholipase D family, member 3 (PLD3), transcript variant 2 from ORIGENE TECHNOLOGIES | LY429360 | 100 ug | ORIGENE TECHNOLOGIES |
| Phospholipase D family, member 5 (PLD5), transcript variant 2 from ORIGENE TECHNOLOGIES | LY434258 | 100 ug | ORIGENE TECHNOLOGIES |
| Phospholipase D2 (PLD2) from ORIGENE TECHNOLOGIES | LY419170 | 100 ug | ORIGENE TECHNOLOGIES |
| Phospholipid scramblase family, member 5 (PLSCR5) from ORIGENE TECHNOLOGIES | LY421291 | 100 ug | ORIGENE TECHNOLOGIES |
| Phospholipid scramblase 1 (PLSCR1) from ORIGENE TECHNOLOGIES | LY402834 | 100 ug | ORIGENE TECHNOLOGIES |
| Phospholipid scramblase 2 (PLSCR2) from ORIGENE TECHNOLOGIES | LY412529 | 100 ug | ORIGENE TECHNOLOGIES |
| Phospholipid scramblase 3 (PLSCR3) from ORIGENE TECHNOLOGIES | LY412530 | 100 ug | ORIGENE TECHNOLOGIES |
| Phospholipid scramblase 4 (PLSCR4), transcript variant 1 from ORIGENE TECHNOLOGIES | LY426943 | 100 ug | ORIGENE TECHNOLOGIES |
| Sulfatase modifying factor 1 (SUMF1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY405331 | 100 ug | ORIGENE TECHNOLOGIES |
| Sulfatase modifying factor 1 (SUMF1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY431307 | 100 ug | ORIGENE TECHNOLOGIES |
| Sulfatase modifying factor 1 (SUMF1), transcript variant 3 from ORIGENE TECHNOLOGIES | LY431311 | 100 ug | ORIGENE TECHNOLOGIES |
| Sulfatase modifying factor 2 (SUMF2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY420922 | 100 ug | ORIGENE TECHNOLOGIES |
| Sulfatase modifying factor 2 (SUMF2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY432183 | 100 ug | ORIGENE TECHNOLOGIES |
| Sulfatase modifying factor 2 (SUMF2), transcript variant 3 from ORIGENE TECHNOLOGIES | LY420923 | 100 ug | ORIGENE TECHNOLOGIES |
| Sulfatase modifying factor 2 (SUMF2), transcript variant 5 from ORIGENE TECHNOLOGIES | LY427143 | 100 ug | ORIGENE TECHNOLOGIES |
| Sulfatase modifying factor 2 (SUMF2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY414574 | 100 ug | ORIGENE TECHNOLOGIES |
| Sulfatase 1 (SULF1), transcript variant 3 from ORIGENE TECHNOLOGIES | LY414761 | 100 ug | ORIGENE TECHNOLOGIES |
| Sulfatase 2 (SULF2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY412877 | 100 ug | ORIGENE TECHNOLOGIES |
| Sulfatase 2 (SULF2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY404800 | 100 ug | ORIGENE TECHNOLOGIES |
| Sulfatase 2 (SULF2), transcript variant 3 from ORIGENE TECHNOLOGIES | LY432060 | 100 ug | ORIGENE TECHNOLOGIES |
| Human aquaporin 1 (Colton blood group) (AQP1) from ORIGENE TECHNOLOGIES | TP305304 | 20 ug | ORIGENE TECHNOLOGIES |
| Human aquaporin 1 (Colton blood group) (AQP1), transcript variant 4. from ORIGENE TECHNOLOGIES | TP329599 | 20 ug | ORIGENE TECHNOLOGIES |
| PAF1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN400103 | 1 kit | ORIGENE TECHNOLOGIES |
| Paf1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN512750 | 1 kit | ORIGENE TECHNOLOGIES |
| Endothelin converting enzyme 1 (ECE1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY419958 | 100 ug | ORIGENE TECHNOLOGIES |
| Endothelin converting enzyme 1 (ECE1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY426400 | 100 ug | ORIGENE TECHNOLOGIES |
| Endothelin converting enzyme 2 (ECE2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY415110 | 100 ug | ORIGENE TECHNOLOGIES |
| Endothelin converting enzyme-like 1 (ECEL1) from ORIGENE TECHNOLOGIES | LY417714 | 100 ug | ORIGENE TECHNOLOGIES |
| Endothelin 2 (EDN2) from ORIGENE TECHNOLOGIES | LY419628 | 100 ug | ORIGENE TECHNOLOGIES |
| Bcl7c - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN502114 | 1 kit | ORIGENE TECHNOLOGIES |
| BCL7C - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN405720 | 1 kit | ORIGENE TECHNOLOGIES |
| BCL6 co-repressor (BCOR), transcript variant 1 from ORIGENE TECHNOLOGIES | LY413571 | 100 ug | ORIGENE TECHNOLOGIES |
| BCL6 co-repressor (BCOR), transcript variant 3 from ORIGENE TECHNOLOGIES | LY426616 | 100 ug | ORIGENE TECHNOLOGIES |